• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Berkshire Hathaway sells 100 mln Apple shares

by November 15, 2024
written by November 15, 2024

Investing.com– Berkshire Hathaway (NYSE:BRKa) sold about a quarter of its stake in Apple Inc (NASDAQ:AAPL), amounting to 100 million shares in the tech giant in the third quarter, a regulatory filing confirmed on Thursday.

Warren Buffet’s firm had announced the sale during its third-quarter earnings earlier this month, with a 13f filing confirming the sale this week. 

The share sale, which was conducted through the course of the July-September quarter, netted Berkshire over $100 billion in cash. But Apple still remained the conglomerate’s biggest holding, of about 300 million shares worth nearly $70 billion.

The company has sold more than 600 million of Apple’s shares in 2024, bringing its cash position to a record $325 billion, as of September 30. 

Investors have fretted over Berkshire’s increased cash position, which indicates a largely risk-off mindset for the firm. The firm’s sales of its Apple holdings also come as the iPhone maker grapples with slowing device sales despite introducing artificial intelligence features in its latest models. China has been a main pressure point on Apple’s sales. 

Thursday’s 13f filing showed Berkshire brought stakes in Domino’s Pizza Inc (NYSE:DPZ) and Pool Corporation (NASDAQ:POOL) in the third quarter. 

But the conglomerate remained a net seller of stocks in the quarter, selling about 235 million shares in Bank of America Corp (NYSE:BAC). The firm also sold almost the entirety of its stake in Brazilian cosmetics chain Ulta Beauty Inc (NASDAQ:ULTA), while cutting its investments in Capital One Financial Corporation (NYSE:COF), Charter Communications Inc (NASDAQ:CHTR) and Nu Holdings Ltd (NYSE:NU). 

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
UK economic growth slowed in third quarter; September GDP fell 0.1%
next post
Health advocates press Cepheid for cheaper mpox tests

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • ‘Shark Tank’ alum Bombas taps former Under Armour exec as CEO as it looks beyond digital roots

      May 16, 2025
    • Netflix says its ad tier now has 94 million monthly active users

      May 15, 2025
    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion

      May 15, 2025
    • YouTube will stream NFL Week 1 game in Brazil for free

      May 15, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (464)
    • Stock (6,426)

    Latest News

    • ‘Shark Tank’ alum Bombas taps former Under Armour exec as CEO as it looks beyond digital roots
    • Netflix says its ad tier now has 94 million monthly active users

    Popular News

    • VW union signals strikes in December but talks continue
    • Merck signs up to $3.3 billion cancer drug deal with China-based LaNova

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy